Submission Details
| 510(k) Number | K133936 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 23, 2013 |
| Decision Date | April 04, 2014 |
| Days to Decision | 102 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K133936 is an FDA 510(k) clearance for the ARTUS C. DIFFICILE QS-RGQ MDX KIT, a C. Difficile Toxin Gene Amplification Assay (Class II — Special Controls, product code OZN), submitted by QIAGEN GmbH (Gaithersburg, US). The FDA issued a Cleared decision on April 4, 2014, 102 days after receiving the submission on December 23, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3130.
| 510(k) Number | K133936 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 23, 2013 |
| Decision Date | April 04, 2014 |
| Days to Decision | 102 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | OZN — C. Difficile Toxin Gene Amplification Assay |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3130 |
| Definition | Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients. |